Quantum Biopharma Ltd. | WebDisclosure

Basculer en Français

10448	Companies
219307	Keywords
148739	Articles
115991	Press releases

Headlines Articles Press releases Quantum Biopharma Ltd.

Home
Companies
Quantum Biopharma Ltd.

PRESS RELEASE

published on 12/20/2024 at 15:15, 1 year 5 months ago

Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
Quantum BioPharma Ltd. purchases $1,000,000 Bitcoin and other cryptocurrencies, allows cryptocurrency transactions, emphasizing compliance and potential returns for shareholders

Bitcoin Compliance Investment Cryptocurrency Quantum BioPharma
BRIEF

published on 12/14/2024 at 01:05, 1 year 5 months ago

Quantum BioPharma conclut la première tranche de son offre

Première Tranche Biopharmacie Quantique Unités D'obligations Développement Du Capital Dollars Canadiens
BRIEF

published on 12/14/2024 at 01:05, 1 year 5 months ago

Quantum BioPharma Concludes Initial Tranche of Offering

First Tranche Capital Development Quantum BioPharma Canadian Dollars Debenture Units
PRESS RELEASE

published on 12/14/2024 at 01:00, 1 year 5 months ago

Quantum Biopharma Announces Closing of First Tranche
Quantum BioPharma closes initial tranche of offering, issuing 500 Debenture Units for $500,000. Proceeds for business development and working capital. Securities subject to statutory hold period

Working Capital Statutory Hold Period Quantum BioPharma Debenture Units Tranche Offering
BRIEF

published on 12/10/2024 at 13:35, 1 year 5 months ago

Quantum Biopharma avance dans l'essai clinique Lucid-MS

Recherche Biopharmaceutique Biopharmacie Quantique Examen De Sécurité Essai Lucid-MS Progrès Clinique
BRIEF

published on 12/10/2024 at 13:35, 1 year 5 months ago

Quantum Biopharma Moves Forward in Lucid-MS Clinical Trial

Biopharmaceutical Research Quantum BioPharma Lucid-MS Trial Clinical Advancement Safety Review
PRESS RELEASE

published on 12/10/2024 at 13:30, 1 year 5 months ago

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)
Quantum BioPharma announces approval to proceed with dosing of second cohort in Lucid-21-302 trial. Company focused on innovative treatments for neurodegenerative disorders

Drug Development Neurodegenerative Disorders Quantum BioPharma Lucid-21-302 Trial Safety Review Committee
BRIEF

published on 12/05/2024 at 13:35, 1 year 5 months ago

Quantum BioPharma Launches Private Placement for $5 Million

Private Placement Convertible Debenture Canadian Market Investment Offering Quantum BioPharma
BRIEF

published on 12/05/2024 at 13:35, 1 year 5 months ago

Quantum BioPharma lance un placement privé de 5 millions de dollars

Placement Privé Marché Canadien Obligation Convertible Biopharmacie Quantique Offre D'investissement
PRESS RELEASE

published on 12/05/2024 at 13:30, 1 year 5 months ago

Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million
Quantum BioPharma announces a non-brokered private placement offering of convertible debenture units. Proceeds for business development and working capital

Private Placement Working Capital Business Development Quantum BioPharma Debenture Units

Accesswire

Published on 05/25/2026 at 13:30, 1 hour 10 minutes ago

ZTEST Electronics Inc. Announces Fiscal 2026 Q3 Results with 13.9% Year Over Year Revenue Growth
Published on 05/25/2026 at 13:30, 1 hour 10 minutes ago

ESgold Corp. Engages ICP Securities for Automated Market Making Services
Published on 05/23/2026 at 19:45, 1 day 18 hours ago

Golden Minerals Announces Closing of Equity Financing
Published on 05/23/2026 at 03:15, 2 days 11 hours ago

UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 2 days 11 hours ago

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges

View all ACCESSWIRE

EQS Group

Published on 05/25/2026 at 14:23, 17 minutes ago

ANT Systems Launches Industrial-Scale Production of Drought Technology Used on Five Continents
Published on 05/25/2026 at 14:23, 17 minutes ago

ANT Systems lance la production à grande échelle de technologies de lutte contre la sécheresse utilisées sur cinq continents
Published on 05/25/2026 at 13:40, 1 hour ago

AFX Launches Mainnet Points Program to Reward Real Traders, Liquidity Providers, and Communities
Published on 05/25/2026 at 12:50, 1 hour 50 minutes ago

Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
Published on 05/25/2026 at 11:05, 3 hours 35 minutes ago

VT Markets Adds 39 US Stocks and ETFs Spanning AI, Space, and Energy

Les Echos

Published on 05/22/2026 at 19:35, 2 days 19 hours ago

PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 2 days 20 hours ago

Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 2 days 20 hours ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 3 days 1 hour ago

Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 3 days 1 hour ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026

View all LES ECHOS COMFI WIRE